| TRDJ1 |
A0A075B706
|
T cell receptor delta joining 1
|
|
|
0.736 |
0.269 |
| TRDD3 |
|
T cell receptor delta diversity 3
|
|
|
0.736 |
0.269 |
| TRDC |
B7Z8K6
|
T cell receptor delta constant
|
|
|
0.729 |
0.269 |
| ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
| TRGC1 |
P0CF51
|
T cell receptor gamma constant 1
|
|
|
0.663 |
0.385 |
| BAALC |
Q8WXS3
|
BAALC binder of MAP3K1 and KLF4
|
|
4.4E-03 |
0.631 |
0.385 |
| P2RY8 |
Q86VZ1
|
P2Y receptor family member 8
|
G-protein coupled receptor
|
3.4E-03 |
0.700 |
0.385 |
| RASSF10 |
A6NK89
|
Ras association domain family member 10
|
|
|
0.626 |
0.385 |
| EVPL |
Q92817
|
envoplakin
|
Cellular structure
|
5.7E-25 |
0.599 |
0.423 |
| TRBV16 |
A0A087WV62
|
T cell receptor beta variable 16 (gene/pseudogene)
|
|
|
0.695 |
0.500 |
| TRBV7-9 |
P04435
|
T cell receptor beta variable 7-9
|
|
|
0.695 |
0.500 |
| TRBC1 |
P01850
|
T cell receptor beta constant 1
|
|
|
0.695 |
0.500 |
| TARP |
|
TCR gamma alternate reading frame protein
|
|
|
0.638 |
0.500 |
| TRB |
P0DSE2
|
T cell receptor beta locus
|
|
|
0.636 |
0.538 |
| TRG |
|
T cell receptor gamma locus
|
|
|
0.631 |
0.538 |
| CRLF2 |
Q9HC73
|
cytokine receptor like factor 2
|
Signaling
|
3.3E-07 |
0.615 |
0.538 |
| FLT3LG |
P49771
|
fms related receptor tyrosine kinase 3 ligand
|
|
0.94 |
0.564 |
0.577 |
| CNTNAP1 |
P78357
|
contactin associated protein 1
|
|
3.4E-05 |
0.554 |
0.577 |
| PRAME |
P78395
|
preferentially expressed antigen in melanoma
|
|
2.4E-07 |
0.531 |
0.577 |
| CD22 |
P20273
|
CD22 molecule
|
|
0.80 |
0.556 |
0.615 |
| HLF |
Q16534
|
HLF transcription factor, PAR bZIP family member
|
Nucleic acid binding
|
0.95 |
0.628 |
0.615 |
| FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
| IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |